In patients admitted for COPD exacerbation, serum levels of the body's own MOTS‑c were lower than in patients with stable COPD.
In plain wordsIn people admitted with a COPD flare-up, the body's own MOTS‑c levels were lower than in people with stable COPD.
- Peptide
- MOTS-c
- Outcome
- DecreaseSerum MOTS-c in ECOPD versus stable COPD
- Study
n = 211
- Comparator
- Stable COPD
- Outcome group
- Mitochondrial function · Respiratory
Source sentences
Serum FGF-21 (p < .001), MOTS-c (p < .001) and Romo1 (p = .002) levels were lower, and GDF-15 (p < .001) levels were higher, in patients with ECOPD than stable COPD, but no differences were found in HN.
1 context sentence(design, population, supporting numbers)
A total of 51 consecutive patients admitted to our hospital for ECOPD were included and followed for 1 year; in addition, 160 participants with stable COPD from our out-patient clinic were recruited as controls.
This result measures the body's own MOTS-c. Nobody was given the peptide. It is not evidence about taking it.